Peripheral T Cell Subpopulation in Patients with Hepatocellular Carcinoma: Relation to Ablation Therapy
نویسندگان
چکیده
منابع مشابه
Percutaneous Local Ablation Therapy for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a prevalent disease in Asia and the second leading cause of cancer death in Hong Kong.1 Surgical resection is regarded as the curative treatment. However, only 20% to 30% of HCC patients are suitable surgical candidates.2,3 Over the years, various locoregional therapies have been employed for the treatment of unresectable HCC. These include the widely practised...
متن کاملCorrection to: Efficacy of Radiofrequency Ablation in Patients with Metastatic Liver Tumors from Breast Carcinoma
In the article published in Volume 27, issue 158, 2017, the Results section in English Abstract have been published incorrectly. The correct Results is given below: Results: The most frequent sizes of mass were 2-4 cm (n=33, 54%) and 4-5 cm (n=23, 38%). Among the patients, 35 (67.3%) had one tumor before, in 11.5% renew tumor happened, and 65.4% had one tumor after treatment. Liver tum...
متن کاملTherapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
BACKGROUND Gemcitabine is a novel nucleoside analogue which has shown promising results in most solid tumors; like the arabinosylcytosine analogue, gemcitabine may be an active drug in lymphoproliferative malignancies. We tested it in pretreated peripheral T-cell lymphoma patients with isolated skin involvement. PATIENTS AND METHODS We performed a phase II study with the drug in 13 pretreated...
متن کاملtranscatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma
conclusions we showed that in treatment of patients with unresectable hepatocellular carcinoma, tace significantly improved the disease and the overall survival rate. also, we introduce the tumor size, serum alp level, and number of liver involved segments as prognostic factors of the procedure. finally, tace can be recommended as the initial treatment for unresectable hcc patients. background ...
متن کاملRecent progress in radiofrequency ablation therapy for hepatocellular carcinoma.
In order to attain better ablation and more effective management of hepatocellular carcinoma (HCC), new approaches and devices in radiofrequency ablation (RFA) therapy were presented and discussed in a workshop at the 50th Annual Meeting of the Liver Cancer Study Group of Japan. A novel bipolar RFA apparatus was introduced in Japan in January 2013. Hundreds of subjects with HCC were treated wit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine: Open Access
سال: 2017
ISSN: 2165-8048
DOI: 10.4172/2165-8048.1000243